Samra Riesebosch
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- Animal Virus Infections Studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 detection and testing 1
-
- Respiratory viral infections research 4
- Co-authors
- Mart M. Lamers (6 shared papers)Bart L. Haagmans (6 shared papers)Debby Schipper (6 shared papers)Anna Z. Mykytyn (6 shared papers)Tim I. Breugem (6 shared papers)Petra B. van den Doel (4 shared papers)Robbert J. Rottier (1 shared paper)Hans Clevers (2 shared papers)
- Journals
- eLife (2 papers)Nature Communications (1 paper)Proceedings of the National Academy of Sciences (1 paper)The EMBO Journal (1 paper)BMC Infectious Diseases (1 paper)
- Partner nations
- NetherlandsSingaporeCanada
In The Last Decade
Samra Riesebosch
7 papers receiving 413 citations
Peers
Comparison fields: 5 of 65
- Infectious Diseases 220
- Animal Science and Zoology 35
- Pulmonary and Respiratory Medicine 88
- Neurology 31
- Epidemiology 69
Countries citing papers authored by Samra Riesebosch
This map shows the geographic impact of Samra Riesebosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samra Riesebosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samra Riesebosch more than expected).
Fields of papers citing papers by Samra Riesebosch
This network shows the impact of papers produced by Samra Riesebosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samra Riesebosch. The network helps show where Samra Riesebosch may publish in the future.
Co-authors
The 25 scholars most cited alongside Samra Riesebosch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 162 | |
| 2 | 2021 | 108 | |
| 3 | 2021 | 73 | |
| 4 | 2021 | 65 | |
| 5 | 2025 | 5 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 2 |
About Samra Riesebosch
Samra Riesebosch is a scholar working on Infectious Diseases, Epidemiology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 7 papers that have together received 420 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Respiratory viral infections research (4 papers), COVID-19 Clinical Research Studies (2 papers), Virus-based gene therapy research (2 papers), SARS-CoV-2 detection and testing (1 paper), Inhalation and Respiratory Drug Delivery (1 paper), Polyomavirus and related diseases (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Infectious Diseases (220 citations), Animal Science and Zoology (35 citations), Pulmonary and Respiratory Medicine (88 citations), Neurology (31 citations) and Epidemiology (69 citations). Samra Riesebosch has collaborated with scholars based in Netherlands, Singapore and Canada. Frequent co-authors include Mart M. Lamers, Bart L. Haagmans, Debby Schipper, Anna Z. Mykytyn, Tim I. Breugem, Petra B. van den Doel, Robbert J. Rottier, Hans Clevers, Joep Beumer and Jelte van der Vaart. Their work appears in journals such as eLife, Nature Communications, Proceedings of the National Academy of Sciences, The EMBO Journal and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.